Recent GSMA Information Papers
- Femtocells and Health (Oct 2007)
This brochure has been designed to answer questions you may have about femtocells. We have all read or heard about concerns raised from time to time regarding the safe use of radio waves and wireless communications equipment. The wireless industry takes these concerns seriously and welcomes ongoing research. The consensus of international health authorities today is that there are no established health effects from low power wireless communications devices such as femtocells.
- Interpreting Epidemiological Studies (Oct 2007)
To date there have been several studies investigating possible associations between adverse health effects and exposure to radiofrequency (RF) electromagnetic fields emitted by radio sources, including mobile phones and radio broadcast towers. Whilst these studies have received public attention, their interpretation is not straightforward due to methodologic difficulties. Furthermore it should be noted that while epidemiological studies can indicate possible factors influencing health, they cannot be used to unequivocally prove causation.
- Conducting Epidemiological Studies on Mobile Base Stations (Oct 2007)
The reliability of epidemiological studies in detecting real associations between illness and environmental factors is limited by, amongst other things, the accuracy and validity of the exposure classification. This is particularly relevant to epidemiological studies testing for associations between illness and radiofrequency (RF) electromagnetic field exposures from mobile base stations. On the current evidence, it appears that it is not feasible to reliably assess individual RF exposures in areas around base stations for epidemiological studies.
Past
GSMA papers
Other Headlines
International: ITU-T Workshop Human exposure to EMFs, 20 Nov, Geneva
Europe: EMFNEAR Study of Potential UMTS/3G Effects on Hearing - Report
Europe: Commission to Postpone and Amend EMF Legislation to Protect MRI
UK: MTHR 2 Call for Research Proposals |